CD274 and malaria: We found an increased risk of susceptibility to Malaria, type I diabetics, Resistance to PD-L1 monoclonal antibodies, depression, Urogenital schistosomiasis, Colorectal Cancer, and resistance to an immune checkpoint inhibitor consistent with previous reports [43,44,45].